v3.26.1
CONTRACT ASSETS AND LIABILITIES (Tables)
9 Months Ended
Jun. 30, 2026
Contract Assets And Liabilities  
SCHEDULE OF CONTRACT ASSETS AND LIABILITIES

The following is a summary of the Company’s uncompleted contracts:

 

 

   June 30, 2026   September 30, 2025 
Costs incurred on uncompleted contracts  $24,096,533   $10,344,923 
Estimated gross profit   8,086,942    4,025,531 
    32,183,475    14,370,454 
Applicable billings to date   (33,044,776)   (15,045,345)
Net billings in excess of costs  $(861,301)  $(674,891)
SUMMARY OF CONTRACT ASSETS AND CONTACT LIABILITIES

  

   June 30, 2026   June 30, 2025   June 30, 2026   June 30, 2025 
   For the three months ended   For the nine months ended 
   June 30, 2026   June 30, 2025   June 30, 2026   June 30, 2025 
Costs and Estimated Earnings in Excess of Billings on Uncompleted Contracts                    
Contract asset, beginning balance  $2,208,539   $1,156,620   $980,164   $985,207 
Changes in revenue billed, contract price or cost estimates   (549,382)   (558,469)   17,138    (387,056)
Contract assets acquired in acquisition   -    -    661,855    - 
Contract asset, net, ending balance  $1,659,157   $598,151   $1,659,157   $598,151 
Billings in Excess of Costs and Estimated Earnings on Uncompleted Contracts                    
Contract liability, beginning balance   (2,500,328)  $(1,924,425)   (1,655,055)  $(1,254,204)
Changes in revenue billed, contract price or cost estimates   (20,130)   (785,165)   (180,922)   (1,455,386)
Contract liabilities acquired in acquisition   -    -    (684,481)   - 
Contract liability, ending balance  $(2,520,458)  $(2,709,590)  $(2,520,458)  $(2,709,590)
Net Billings in Excess of Costs and Estimated Earnings on Uncompleted Contracts                    
Net billings in excess of costs, beginning balance  $(291,789)  $(767,805)  $(674,891)  $(268,997)
Changes in revenue billed, contract price or cost estimates   (569,512)   (1,343,634)   (163,784)   (1,842,442)
Net billings in excess of costs acquired in acquisition   -    -    (22,626   - 
Net (earnings in excess of billings)/costs in excess of billings, ending balance  $(861,301)  $(2,111,439)  $(861,301)  $(2,111,439)